Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth.
Publication
, Conference
Kovach, AR; Linardic, CM
Published in: MOLECULAR CANCER RESEARCH
2020
Duke Scholars
Published In
MOLECULAR CANCER RESEARCH
EISSN
1557-3125
ISSN
1541-7786
Publication Date
2020
Volume
18
Issue
8
Start / End Page
26 / 26
Related Subject Headings
- Oncology & Carcinogenesis
- Developmental Biology
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Kovach, A. R., & Linardic, C. M. (2020). Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth. In MOLECULAR CANCER RESEARCH (Vol. 18, pp. 26–26).
Kovach, Alexander R., and Corinne M. Linardic. “Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth.” In MOLECULAR CANCER RESEARCH, 18:26–26, 2020.
Kovach AR, Linardic CM. Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth. In: MOLECULAR CANCER RESEARCH. 2020. p. 26–26.
Kovach, Alexander R., and Corinne M. Linardic. “Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth.” MOLECULAR CANCER RESEARCH, vol. 18, no. 8, 2020, pp. 26–26.
Kovach AR, Linardic CM. Genetic and pharmacologic inhibition of HES1 reduces YAP1 expression, impairing rhabdomyosarcoma cell growth. MOLECULAR CANCER RESEARCH. 2020. p. 26–26.
Published In
MOLECULAR CANCER RESEARCH
EISSN
1557-3125
ISSN
1541-7786
Publication Date
2020
Volume
18
Issue
8
Start / End Page
26 / 26
Related Subject Headings
- Oncology & Carcinogenesis
- Developmental Biology
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
- 1112 Oncology and Carcinogenesis